# Estrogen in the Prevention of Adhesion Reformation

> **NCT03620929** · PHASE4 · UNKNOWN · sponsor: **Fu Xing Hospital, Capital Medical University** · enrollment: 186 (estimated)

## Conditions studied

- Asherman Syndrome

## Interventions

- **DRUG:** Estradiol Valerate

## Key facts

- **NCT ID:** NCT03620929
- **Lead sponsor:** Fu Xing Hospital, Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-13
- **Primary completion:** 2018-08-13
- **Final completion:** 2022-12-01
- **Target enrollment:** 186 (ESTIMATED)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03620929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03620929, "Estrogen in the Prevention of Adhesion Reformation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03620929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*